| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
09-13-2017, 06:15 AM
|
#1 | ||
|
|||
|
Member
|
"The interaction between L-DOPA and 5-HT transmission is especially relevant in those Parkinson's disease (PD) patients that suffer dyskinesia, comorbid anxiety or depression, since the efficacy of antidepressants or 5-HT compounds may be affected."
Frontiers | Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications | Frontiers in Cellular Neuroscience |
||
|
 Reply With Quote
|
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Implications of Breathing Dysfunction and TOS | Thoracic Outlet Syndrome | |||
| NYT article on disclosure implications | Parkinson's Disease | |||
| Iron Deficiency and Excess in the Brain: Implications for Cognitive Impairment and N | Parkinson's Disease | |||
| Depression in PD related to catecholaminergic rather than serotonergic system | Parkinson's Disease | |||
| Consider the possible implications | Parkinson's Disease | |||
Impairment of Serotonergic Transmission by L-DOPA - Mechanisms and Implications
Threaded Mode